Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
Completed
Conditions studied: Outcomes Following Restor IOL Lens Implant
In brief
To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas
Key facts
- Study ID
- NCT00344578
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 120
- Starts
- 2006-03-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2011-03-23
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients of any race and sex between the ages of 18-90 years of age who have undergone ReSTOR® IOL cataract surgery will be recruited in this retrospective project.
You may not qualify if…
- Patients who underwent conventional IOL cataract extraction surgery
Where it is running
- Aston Ambulatory Care Center — Dallas, Texas, United States
- UTSW Medical Center at Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.